Drug Type Small molecule drug |
Synonyms ABSK051 |
Target |
Mechanism CD73 inhibitors(5'-nucleotidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 14 Dec 2023 | |
Neoplasms | IND Application | CN | 23 Aug 2022 |